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IntroducLon	  	  
The	   electroencephalogram	   during	   anaesthesia	   may	   be	  
aﬀected	   by	   brain	   tumour.	   We	   studied	   whether	  
paLents	   with	   unilateral	   or	   centrally	   located	   brain	  
tumours	   have	   diﬀerent	   BIS	   readings	   at	   Loss	   Of	  
Response	   to	   Name	   Calling	   (LORNC)	   in	   healthy	  
versus	   diseased	   hemispheres.	   	   We	   compared	  
tumour	  paLents	  with	  healthy	  control	  paLents.	  We	  
hypothesize	   that	   the	   presence	   of	   tumour	   evokes	  
larger	   assymetry	   in	   bilateral	   BIS	   at	   LORNC	  
compared	  to	  healthy	  control	  paLents.	  	  
Methods	  	  
AUer	   EC	   approval	   and	   informed	   consent,	   40	   ASA	   1	   or	   2	  
paLents	   (Control	   group)	   and	   41	   paLents	   with	  
intracranial	   tumour	   (Tumour	   group)	   received	   a	  
standardized	  anaesthesia	  while	  measuring	  bilateral	  
BIS	  using	  BIS	  VISTAXP4	  monitor	  and	  bilateral	  sensor	  
(Covidien,Dublin,Ireland)(ﬁgure	   1)	   All	   data	   was	  
collected	   using	   RUGloop	   II.	   (Demed,	   Temse,	  
Belgium)	  Remifentanil	  was	  started	  at	  3	  or	  5	  ng/ml	  
eﬀect-­‐site	   concentraLon	   (CeREMI)	   (Minto	   Model)	  
and	   maintained	   throughout	   the	   study.	   	   Propofol	  
was	  set	  at	  2	  µg/ml	   (CePROP)	   (Schnider	  model,	  ﬁxed	  
Lme	   to	   peak	   eﬀect)	   and	   increased	   with	  
incremental	  steps	  of	  0.5	  µg/ml.	  	  	  Every	  15	  seconds,	  
the	   Observers’	   Assessment	   of	   Alertness	   and	  
SedaLon	   scale	   was	   determined	   unLl	   LORNC	   was	  
observed.	   	  A	   t-­‐test	  compared	  BIS	  compaLble	  with	  
LORNC	   between	   healthy	   versus	   diseased	  
hemispheres	   within	   and	   between	   control	   and	  
tumour	  paLents.	   	  StaLsLcal	  signiﬁcance	  was	  set	  at	  
p<0.05.	  
Conclusions	  	  
No	  diﬀerence	  is	  found	  in	  BIS	  assymetry	  between	  individuals	  with	  or	  without	  brain	  tumour.	  In	  both	  
groups,	  unilateral	  BIS	  monitoring	  is	  equally	  eﬀecLve	  for	  detecLng	  LORNC,	  compared	  to	  bilateral	  BIS.	  
The	  higher	  BIS	  values	  at	  LORNC	  in	  some	  tumour	  paLents	  are	  mainly	  acributable	  to	  diﬀerences	  in	  
CePROP	  at	  LORNC	  rather	  than	  to	  tumour	  related	  causes.	  
Results	  	  
No	  demographic	  diﬀerences	  are	   found	  between	  groups.	  except	  
for	   age.	   (table	   1)	   Time	   to	   LORNC	   is	   signiﬁcantly	   shorter	   in	   the	  
tumour	   group	   (536s	   (±162))	   compared	   to	   control	   group	   (604s	  
(±148)).	   CePROP	   	   at	   LORNC	   is	   signiﬁcantly	   lower	   in	   the	   overall	  
tumour	   group	   (2.89	   µg/ml	   (±0.8))	   compared	   to	   control	   group	  
(3.32	  (±0.86)).	  PaLents	  with	  tumour	  located	  centrally	  in	  the	  brain	  
or	   in	  the	  right	  hemisphere	  have	  higher	  BIS	  at	  LORNC	  compared	  
to	   control	   paLents	   or	   paLents	   with	   tumour	   in	   the	   leU	  
hemisphere.	  (ﬁgure	  2)	  No	  staLsLcal	  signiﬁcant	  BIS	  asymmetry	  is	  















group	   46	  ±	  1	  *	   76	  ±	  15	   171	  ±	  10	   604	  ±	  148	  
Tumour	  
group	   50	  ±	  16	  *	   74	  ±	  15	   172	  ±	  10	   536	  ±	  162	  
Table	  1	  
LORNC	   BIS	  leU	  (mean±SD)	  
BIS	  right	  
(mean±SD)	  
Control	  group	   71	  ±	  9	   71	  ±	  11	  
LeU	  Tumour	  group	   65	  ±	  14	   64	  ±	  	  14	  	  	  
Right	  Tumour	  group	   75	  ±	  9	   75	  ±	  11	  
Central	  Tumour	  
group	   79	  ±	  10	   74	  ±	  13	  
Table	  2	  
*p<0.05	  
